https://www.dailyhealthindustry.it/bayer-per-la-divisione-farmaceutica-un-2026-resiliente/ 2026-03-06T10:40:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-dallema-nuove-linee-guida-per-le-emergenze-di-salute-pubblica-in-ue/ 2026-03-06T13:42:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-della-prostata-documento-fondazione-aiom-la-qualita-di-vita-deve-diventare-un-endpoint-primario/ 2026-03-06T14:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dai-silos-al-team-la-cura-cambia-quando-cambia-lorganizzazione/ 2026-03-07T11:17:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/excellence-show-5-sostenibilita-competitiva-quando-lesg-smette-di-essere-marketing/ 2026-03-07T11:07:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/excellence-show-6-verba-volant-acta-manent-linnovazione-aperta-che-arriva-fino-al-paziente/ 2026-03-07T11:20:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-un-dossier-per-capire-come-lia-sta-rivoluzionando-il-mondo-del-pharma/ 2026-03-08T15:35:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/colangite-biliare-primitiva-gsk-cede-i-diritti-di-linerixibat-ad-alfasigma/ 2026-03-09T08:56:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/compugroup-medical-acquisisce-new-line-ricerche-di-mercato-e-rafforza-le-soluzioni-data-driven-per-la-sanita/ 2026-03-09T11:10:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-arianna-gregis-e-la-nuova-ad/ 2026-03-09T16:13:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-approva-approva-ribociclib-per-ridurre-il-rischio-di-recidiva-nel-tumore-al-seno-in-fase-iniziale/ 2026-03-09T14:18:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-menarini-alza-lasticella-4887-mld-di-fatturato-nel-2025-62/ 2026-03-09T14:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-investe-nelloncologia-pediatrica-acquisita-la-statunitense-day-one-biopharmaceuticals-per-25-miliardi-di-dollari/ 2026-03-09T16:07:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-dopo-un-mandato-controverso-vinay-prasad-lascia-lagenzia/ 2026-03-09T15:47:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-obinutuzumab-efficace-nel-controllo-del-les-i-dati-dello-studio-allegory-su-nejm/ 2026-03-10T09:58:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-piu-snelle-per-i-biosimilari-meno-test-pk-piu-approvazioni-rapide/ 2026-03-10T10:53:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-cede-bu-capsule-e-ingredienti-per-la-salute-a-lone-star-per-3-miliardi-di-dollari/ 2026-03-10T11:37:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-da-aifa-ok-a-rimborsabilita-di-seladelpar-nella-colangite-biliare-primitiva/ 2026-03-10T13:53:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/egualia-riccardo-zagaria-doc-pharma-nuovo-presidente/ 2026-03-10T14:41:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-svolta-storica-i-fondatori-lasciano-per-una-nuova-startup-mrna/ 2026-03-11T13:21:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-una-bu-autonoma-per-i-biosimilari/ 2026-03-11T14:07:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-ok-ce-per-zynyz-prima-immunoterapia-sistemica-per-il-carcinoma-a-cellule-squamose-del-canale-anale/ 2026-03-11T14:47:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-15-miliardi-di-dollari-per-espandere-lo-stabilimento-di-plasmaderivati-in-illinois/ 2026-03-11T15:31:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-3-miliardi-di-dollari-in-cina-per-rafforzare-la-produzione-di-orforglipron/ 2026-03-12T09:40:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/india-a-febbraio-il-mercato-farmaceutico-cresce-dell11/ 2026-03-12T10:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-evaluate-pharma-2026-malattie-rare-un-mercato-da-400-miliardi-di-dollari-entro-il-2032/ 2026-03-12T14:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/santhera-pharmaceuticals-vamorolone-conferma-benefici-a-lungo-termine-nella-dmd/ 2026-03-12T15:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-progressi-nella-lotta-allhiv-1-con-dor-isl-primo-regime-non-insti-a-due-farmaci/ 2026-03-13T14:20:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-collaborazione-con-bespak-per-la-produzione-di-inalatori-a-basse-emissioni-nel-regno-unito/ 2026-03-13T13:44:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alert-lilly-copie-di-zepbound-potrebbero-essere-pericolose-lazienda-chiede-lintervento-della-fda/ 2026-03-13T14:18:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-un-top-manager-per-guidare-ladozione-dellai/ 2026-03-13T15:23:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-al-via-servizio-di-video-interpretariato-in-lis-per-i-dipendenti-aifa-al-via-servizio-di-video-interpretariato-in-lis-per-i-dipendenti-con-disabilita-uditiva/ 2026-03-16T10:30:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-tumore-al-seno-il-sud-fa-rete-con-il-modello-beacon/ 2026-03-16T11:09:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/exeltis-allarga-il-proprio-business-alla-neurologia/ 2026-03-16T13:32:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotici-loms-indica-tre-priorita-globali-per-orientare-la-ricerca/ 2026-03-16T14:03:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-le-serie-a-women-in-campo-con-ladesivo-messaggio-blocca-lhpv-con-la-vaccinazione/ 2026-03-17T10:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-raddoppia-in-asia-per-orforglipron-dopo-la-cina-produzione-e-supply-chain-rafforzate-in-giappone/ 2026-03-17T11:18:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dubai-hub-delle-life-sciences-tra-investimenti-e-tensioni-geopolitiche/ 2026-03-17T15:16:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-efpia-lue-e-uneccellenza-scientifica-tradurre-questa-capacita-in-investimenti-farmaceutici-porterebbe-120-miliardi-in-10-anni/ 2026-03-17T15:09:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-aifa-approva-la-rimborsabilita-di-garadacimab-nellangioedema-ereditario/ 2026-03-18T10:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-sceglie-sara-villa-come-patient-advocacy-manager/ 2026-03-18T11:13:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-sulla-pipeline-biosimilari-collaborazione-con-samsung-bioepis/ 2026-03-18T14:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dal-programma-prime-nuovi-strumenti-per-lo-sviluppo-dei-farmaci-destinati-agli-unmet-needs/ 2026-03-18T16:04:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-chiarisce-sulla-rimborsabilita-di-lecanemab-e-donanemab-per-lalzheimer/ 2026-03-19T10:33:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/modelli-regolatori-quanto-si-assomigliano-ema-e-fda/ 2026-03-19T16:55:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-ok-fda-a-linerixibat-nella-colangite-biliare-primitiva/ 2026-03-19T13:23:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-diabete-risultati-positivi-per-triplo-agonista-retatrutide-dallo-studio-transcend-t2d-1/ 2026-03-19T14:31:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-nuova-sede-a-milano/ 2026-03-19T15:17:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-accelera-lo-stop-alla-sperimentazione-animale-e-lancia-una-bozza-di-linee-guida-sulle-nams/ 2026-03-19T16:19:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ipertensione-resistente-ai-farmaci-parere-europeo-positivo-per-la-quadripillola/ 2026-03-23T11:12:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-terapie-car-t-in-cina-con-un-nuovo-stabilimento-a-shanghai/ 2026-03-23T11:53:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-istat-2026-export-boom-per-il-pharma-verso-gli-usa-ma-cresce-la-dipendenza-dalla-cina/ 2026-03-23T13:26:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiom-e-quotidiano-sanita-insieme-per-qs-oncologia-ecco-la-nuova-piattaforma-di-confronto/ 2026-03-23T13:54:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-tumore-della-prostata-mhspc-via-libera-ue-alla-combinazione-a-base-di-niraparib-piu-aap-nei-pazienti-con-mutazioni-brca/ 2026-03-23T14:13:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-3-miliardi-di-dollari-a-synnovation-therapeutics-per-candidato-polivalente/ 2026-03-23T14:50:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-via-libera-fda-a-wegovy-hd-la-dose-piu-alta-di-semaglutide/ 2026-03-23T15:35:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-allo-spallanzani-la-formazione-tobia-sanita-piu-inclusiva-per-la-disabilita-complessa/ 2026-03-24T09:57:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-e-fiaso-alleanza-strategica-per-la-sicurezza-dei-pazienti-lappropriatezza-delle-cure-e-la-sostenibilita-del-ssn/ 2026-03-24T10:07:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-linfoma-di-hodgkin-nuove-indicazioni-per-nivolumab-ok-da-fda-e-commissione-europea/ 2026-03-24T10:53:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-investe-nelle-malattie-autoimmuni-acquisita-ouro-medicines-per-22-miliardi-di-dollari/ 2026-03-24T11:42:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-malattie-rare-laifa-approva-rimborsabilita-di-omaveloxolone-nellatassia-di-friedreich/ 2026-03-24T13:51:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-negoziazione-dei-farmaci-via-alle-nuove-procedure-semplificate-e-fast-track/ 2026-03-24T14:06:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amcham-e-luiss-libro-bianco-sulle-imprese-farmaceutiche-statunitensi-in-italia-una-produzione-che-vale-oltre-9-miliardi-di-euro/ 2026-03-24T15:12:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-off-patent-egualia-senza-interventi-mirati-rischio-carenze-e-uscita-dal-mercato-di-molti-medicinali-essenziali/ 2026-03-24T15:49:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-oltre-1-miliardo-di-dollari-per-candidato-anticorpo-tri-specifico-contro-malattie-autoimmuni/ 2026-03-25T09:46:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-marstacimab-prima-profilassi-sottocutanea-per-emofilia-a-e-b-rimborsabile-in-italia/ 2026-03-25T10:43:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-da-22-miliardi-con-quotient-therpaeutics-per-nuovi-target-ibd/ 2026-03-25T11:48:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardio-hub-daiichi-sankyo-italia-punta-su-ascolto-e-co-progettazione-per-le-patologie-cardiovascolari/ 2026-03-25T14:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scienze-della-vita-leuropa-prova-a-riscrivere-le-regole-per-non-perdere-la-sfida-globale/ 2026-03-25T16:50:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aderenza-terapeutica-le-iniziative-del-gruppo-servier-in-italia-per-la-giornata-mondiale/ 2026-03-26T14:11:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/via-libera-dal-cda-alla-rimborsabilita-di-un-nuovo-farmaco-di-7-estensioni-di-indicazioni-terapeutiche-e-di-3-equivalenti/ 2026-03-26T16:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-della-distribuzione-dei-farmaci-due-anni-di-rivoluzione-gentile-per-la-prossimita/ 2026-03-26T15:29:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-2025-svelati-i-top-of-the-year/ 2026-03-26T16:38:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-strategia-post-keytruda-acquisita-terns-pharmaceuticals-per-67-miliardi-di-dollari/ 2026-03-26T16:54:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-tempus-ai-insieme-per-accelerare-gli-adc-in-oncologia/ 2026-03-27T10:15:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-nuovo-stabilimento-di-farmaci-biologici-in-georgia/ 2026-03-27T11:13:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-nel-mirino-di-cvc-sul-tavolo-offerta-da-109-miliardi-di-euro/ 2026-03-27T14:52:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-focus-sullallergologia-acquisita-la-biotech-excellergy-per-2-miliardi-di-dollari/ 2026-03-27T15:42:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-acquisisce-transcend-therapeutics-per-700-milioni-di-dollari/ 2026-03-30T13:28:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-accordo-da-275-miliardi-di-dollari-con-insilico-per-le-terapie-ai-driven/ 2026-03-30T09:45:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-parere-positivo-del-chmp-per-isatuximab-sottocute-nel-mieloma-multiplo-anche-con-iniettore-indossabile/ 2026-03-30T10:52:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharmamar-ok-chmp-a-lurbinectedina-in-combinazione-con-atezolizumab-nel-tumore-polmonare-a-piccole-cellule/ 2026-03-30T13:04:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/opella-gonzalo-balcazar-nuovo-presidente-europa-e-america-latina/ 2026-03-31T08:55:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-crescita-nel-2025-tra-pipeline-mercati-internazionali-e-nuove-partnership/ 2026-03-31T10:00:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-aifa-rimborsabilita-per-iptacopan-nella-glomerulopatia-da-c3/ 2026-03-31T10:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-flu-coalition-una-nuova-alleanza-per-aumentare-la-prevenzione-dellinfluenza-in-italia/ 2026-03-31T13:47:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-acquisisce-apellis-per-56-miliardi-e-punta-su-nefrologia-e-oftalmologia/ 2026-03-31T14:32:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-propone-di-sostituire-i-gruppi-di-controllo-animali-con-comparatori-virtuali-lobiettivo-e-ridurre-la-sperimentazione-animale/ 2026-04-01T09:21:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-continua-lo-shopping-acquisita-la-biotech-centessa-per-63-miliardi-di-dollari/ 2026-04-01T15:22:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-via-libera-ce-a-belumosudil-per-il-trattamento-della-malattia-cronica-da-trapianto-contro-lospite/ 2026-04-01T14:35:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-laderenza-terapeutica-come-leva-per-innovazione-e-sostenibilita-della-sanita-pubblica/ 2026-04-01T15:33:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jelena-ivanovic-aifa-eletta-co-chair-del-sottogruppo-per-lidentificazione-delle-tecnologie-sanitarie-emergenti-in-europa/ 2026-04-01T15:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-arriva-il-via-libera-fda-per-orforglipron-la-pillola-anti-obesita-a-giorni-il-lancio-con-il-brand-foundayo/ 2026-04-02T09:21:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-efpia-il-motore-economico-degli-studi-clinici-in-europa/ 2026-04-02T12:47:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-vertici-di-aifa-in-missione-istituzionale-in-giappone/ 2026-04-02T10:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-casa-bianca-pronta-a-colpire-le-aziende-che-non-investono-negli-usa-con-dazi-del-100/ 2026-04-02T13:22:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-acquisisce-la-divisione-cromatografia-di-jsr-per-accelerare-la-produzione-di-farmaci-biologici/ 2026-04-03T10:34:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipo-biotech-nel-primo-trimestre-2026-andamento-lento-ma-vendita-azioni-piu-remunerativa/ 2026-04-03T13:27:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-sigla-accordo-con-startup-usa-per-lo-sviluppo-di-nuove-terapie-anticorpali/ 2026-04-03T14:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologie-accordo-triennale-italia-stati-uniti-biotecnopolo-di-siena-al-lavoro-su-linee-guida-e-progetti-strategici/ 2026-04-03T14:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-punta-sulle-partnership-accordi-con-sanofi-e-pfizer-per-valorizzare-ladiuvante-matrix-m/ 2026-04-07T09:31:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stada-arriva-in-italia-lecigimon-per-il-parkinson-in-stadio-avanzato/ 2026-04-07T09:49:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-un-mercato-sempre-piu-caldo-neurocrine-acquisisce-soleno-per-29-miliardi-di-dollari/ 2026-04-07T10:14:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-la-spesa-del-ssn-supera-i-66-miliardi/ 2026-04-07T10:48:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/staar-surgical-stefano-rizza-nuovodirector-italy/ 2026-04-07T13:08:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accelera-sugli-adc-acquisita-la-biotech-tubulis-per-5-miliardi-di-dollari/ 2026-04-08T09:05:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-15-milioni-ad-halozyme-per-sviluppare-nuovi-farmaci-sottocutanei/ 2026-04-08T15:43:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-ok-chmp-a-daratumumab-sottocutaneo-in-autosomministrazione/ 2026-04-08T10:47:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boom-dellma-biotech-a-marzo-segnali-positivi-per-il-2026/ 2026-04-08T13:46:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-incontra-e-aifa-ascolta-pubblicati-in-gu-i-regolamenti/ 2026-04-08T14:28:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pnrr-e-sanita-territoriale-lo-spallanzani-forma-330-manager-del-ssn/ 2026-04-09T08:53:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/steven-ubl-lascia-la-guida-della-phrma-lassociazione-dellindustria-farmaceutica-usa/ 2026-04-09T10:28:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-firma-un-contratto-con-barda-per-produrre-un-antibiotico-negli-usa/ 2026-04-09T12:25:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loms-lancia-il-nuovo-database-per-supportare-i-paesi-europei-nella-gestione-dei-dati-sanitari/ 2026-04-09T12:46:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazione-accessibile-la-leva-che-unisce-salute-crescita-e-competitivita-ogni-euro-investito-in-sanita-ne-genera-fino-a-4-di-pil/ 2026-04-09T15:26:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-mavacamten-raggiunge-endpoint-primario-nello-studio-su-cardiomiopatia-ipertrofica-ostruttiva-negli-adolescenti/ 2026-04-10T09:48:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/doc-pharma-acquisisce-ematonil-plus-da-bayer-e-rafforza-il-portafoglio-otc/ 2026-04-10T10:32:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceva-salute-animale-sebastien-huron-nuovo-direttore-generale/ 2026-04-10T12:27:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oxford-biotherapeutics-accordo-con-bristol-myers-squibb-per-cellule-t-engager-nei-tumori-solidi/ 2026-04-10T13:03:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-punta-sui-dac-accordo-da-oltre-1-miliardo-di-dollari-con-c4-therapeutics/ 2026-04-13T09:22:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-youtube-e-il-momento-dei-video-brevi/ 2026-04-13T10:16:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-testa-e-collo-cresce-il-mercato-globale-immunoterapia-sempre-piu-centrale/ 2026-04-13T14:29:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-punta-sui-radiofarmaci-accordo-da-21-miliardi-con-telix/ 2026-04-13T15:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-terapie-efficaci-ma-accesso-e-aderenza-restano-una-sfida-i-dati-dellopen-day-di-fondazione-onda-ets/ 2026-04-15T07:10:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-nuovo-deal-nelloncologia-di-precisione-acquisita-crossbridge-bio-per-300-milioni-di-dollari/ 2026-04-15T09:45:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accord-healthcare-italia-nicola-mazzanti-e-il-nuovo-country-director/ 2026-04-15T10:22:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parte-steps-4-future-confindustria-dm-e-sport-senza-frontiere-per-linclusione-sociale/ 2026-04-15T10:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-assetti-in-beone-silvia-ottolina-franchise-head-solid-tumors-e-roberto-damele-franchise-head-hematology/ 2026-04-15T12:48:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-punta-sulla-cina-per-rafforzare-la-pipeline-del-dolore/ 2026-04-15T14:19:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-asse-con-lai-il-ceo-narasimhan-entra-nel-board-di-anthropic/ 2026-04-16T15:35:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-si-concentra-sulloncologia-via-libera-alla-vendita-otc-a-suntory/ 2026-04-16T09:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-sceglie-openai-per-sviluppare-nuovi-farmaci/ 2026-04-16T12:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-cresce-nel-q1-e-alza-le-stime-per-il-2026/ 2026-04-16T13:39:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-amazon-nel-mercato-dellai-generativa-per-il-pharma-con-bio-discovery/ 2026-04-16T15:00:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdc-dopo-mesi-di-caos-trump-nomina-erica-schwartz-alla-direzione/ 2026-04-17T09:57:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-italia-export-in-crescita-a-febbraio-ma-pesano-le-flessioni-verso-svizzera-e-regno-unito-i-dati-istat/ 2026-04-17T10:24:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-vende-sofar-a-fine-foods-e-rafforza-il-focus-terapeutico/ 2026-04-17T12:32:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molteni-farmaceutici-ottiene-i-diritti-per-ryzneuta-in-italia-e-polonia/ 2026-04-17T13:30:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-nuove-evidenze-real-world-supportano-cefiderocol-nelle-infezioni-da-patogeni-multiresistenti/ 2026-04-17T15:08:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-di-precisione-laifa-traccia-la-rotta-non-un-lusso-per-pochi-ma-un-diritto-per-tutti/ 2026-04-20T09:13:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kedrion-cresce-nel-2025-ricavi-a-165-miliardi-e-spinta-dagli-stati-uniti/ 2026-04-20T09:22:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emofilia-con-inibitori-in-italia-arriva-concizumab-di-novo-nordisk/ 2026-04-20T09:56:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-al-seno-prevenire-la-recidiva-con-un-gioco-di-squadra-al-via-la-campagna-novartis/ 2026-04-20T12:59:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-accordo-con-interna-per-la-drug-delivery-con-molecole-mnm/ 2026-04-20T14:34:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-acquisisce-kelonia-e-rafforza-la-scommessa-sulle-car-t-in-vivo/ 2026-04-21T10:19:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-apre-a-londra-un-hub-per-accelerare-sullintelligenza-artificiale/ 2026-04-21T10:24:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-compra-neurona-e-amplia-il-presidio-nellepilessia/ 2026-04-21T10:26:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-lepf-chiede-una-revisione-che-non-sacrifichi-accesso-e-trasparenza/ 2026-04-21T10:40:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-alza-le-stime-per-il-2026-dopo-un-primo-trimestre-in-crescita/ 2026-04-21T16:43:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tozorakimab-riduce-le-riacutizzazioni-della-bpco-nello-studio-miranda/ 2026-04-22T08:41:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fenebrutinib-nella-sm-recidivante-risultati-positivi-dagli-studi-fenhance-1-e-2/ 2026-04-22T14:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fabrizio-giombini-alla-guida-di-visufarma-italia-nel-nuovo-assetto-del-gruppo-lupin/ 2026-04-22T17:16:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-fda-a-combo-once-daily-doravirina-islatravir-nellhiv/ 2026-04-22T13:49:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-al-congresso-escmid-nello-studio-compare-meno-effetti-avversi-con-il-vaccino-proteico-anti-covid-19/ 2026-04-23T09:52:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-corre-nel-q1-2026-vendite-a-doppia-cifra-trainate-dai-nuovi-lanci-e-da-dupilumab/ 2026-04-23T09:35:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-investe-14-miliardi-in-north-carolina-nuovo-hub-produttivo-a-durham/ 2026-04-23T10:18:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-via-libera-ce-a-tovorafenib-nel-glioma-pediatrico-di-basso-grado-recidivato-o-refrattario/ 2026-04-23T10:38:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/egualia-avverte-la-revisione-aifa-sui-farmaci-off-patent-rischia-effetti-sul-sistema/ 2026-04-23T12:47:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-lue-autorizza-il-primo-vaccino-mrna-combinato-contro-influenza-e-covid/ 2026-04-23T16:43:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-accelera-nel-2025-malattie-rare-motore-della-crescita-accogli-lascia-la-guida/ 2026-04-23T14:19:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-la-terza-edizione-della-nave-della-salute-italia-albania/ 2026-04-23T15:16:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-ok-fda-alla-prima-terapia-genica-per-la-sordita/ 2026-04-24T13:01:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-google-cloud-alleati-sullintelligenza-artificiale-avanzata-partnership-da-1-miliardo-di-dollari/ 2026-04-24T09:34:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-approva-rimborsabilita-di-4-nuovi-farmaci-9-estensioni-dindicazione-e-6-equivalenti/ 2026-04-24T10:51:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-per-lalzheimer-audite-in-aifa-societa-di-neurologia-e-associazioni-dei-pazienti/ 2026-04-24T13:36:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/testo-unico-della-legislazione-farmaceutica-istituzioni-e-industria-a-confronto-sulle-sfide-del-sistema-in-dovere-di-parola/ 2026-04-24T14:04:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-chmp-a-a-tolebrutinib-nella-sclerosi-multipla-secondariamente-progressiva/ 2026-04-24T16:39:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-gsk-chiuso-laccordo-per-i-diritti-globali-di-linerixibat/ 2026-04-27T09:08:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-ok-aifa-al-biosimilare-di-omalizumab-per-lasma-allergico/ 2026-04-27T09:37:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-potenzia-lofferta-globale-acquisita-organon-per-1175-miliardi-di-dollari/ 2026-04-27T14:23:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mieloma-multiplo-rimborsata-car-t-cilta-cel-utilizzabile-dalla-seconda-linea/ 2026-04-27T16:18:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mdw-il-parametro-dellemocromo-che-supporta-la-gestione-dei-pazienti-ematologici-complessi/ 2026-04-28T09:01:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allo-spallanzani-nasce-la-rete-degli-irccs-del-lazio/ 2026-04-28T09:11:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-commissione-europea-approva-remibrutinib-per-lorticaria-cronica-spontanea/ 2026-05-04T10:04:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-efimosfermin-doppia-designazione-accelerata-fda-ema-per-la-mash/ 2026-04-28T10:25:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-deal-in-ematologia-acquisita-la-biotech-ajax-therapeutics/ 2026-04-28T13:14:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nistico-advocacy-trasparente-e-strutturata-per-migliorare-le-politiche-del-farmaco/ 2026-04-28T16:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-apre-alle-terapie-digitali-accordo-con-remepy-nelloncologia-rara/ 2026-04-29T06:58:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vas-narasimhan-ceo-novartis-revisione-dei-sistemi-di-pricing-in-europa-o-ritardi-nei-nuovi-farmaci/ 2026-04-29T09:03:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-boehringer-ingelheim-sfida-le-big-survodutide-raggiunge-endpoint-principale-nello-studio-synchronize-1/ 2026-04-29T10:43:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-maxi-deal-nelle-malattie-rare-acquisita-kalvista-per-19-miliardi-di-dollari/ 2026-04-29T13:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-eurostat-le-esportazioni-di-farmaci-sostengono-926-000-posti-di-lavoro-nellue-quasi-raddoppiati-in-13-anni/ 2026-04-29T13:44:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fidia-crescita-a-doppia-cifra-dellebitda-e-consolidamento-internazionale-nel-2025/ 2026-04-30T10:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-punta-su-emalex-per-le-neuroscienze-acquisizione-da-900-milioni-di-dollari/ 2026-04-30T15:06:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-ultra-rare-la-commissione-europea-autorizza-mavorixafor-di-norgine-primo-farmaco-per-la-sindrome-whim/ 2026-04-30T13:38:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-un-nuovo-impianto-api-in-north-carolina-completa-piano-da-23-miliardi-di-investimenti-in-usa/ 2026-04-30T14:07:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-punta-sullediting-genetico-accordo-da-225-miliardi-di-dollari-con-profluent/ 2026-04-30T14:57:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/citarrella-confindustria-dm-in-europa-regole-piu-chiare-per-rafforzare-competitivita-e-accesso-alle-tecnologie/ 2026-04-30T16:15:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-la-commissione-europea-estende-dupilumab-allorticaria-cronica-spontanea-pediatrica/ 2026-05-04T10:04:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-roche-al-via-la-decima-edizione-del-bando-per-la-ricerca-indipendente/ 2026-05-04T10:42:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-aifa-approva-la-formulazione-sottocutanea-di-nivolumab-e-nuove-indicazioni-nei-tumori-solidi/ 2026-05-04T13:09:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neopharmed-gentili-accordo-esclusivo-con-biocryst-per-navenibart-in-europa/ 2026-05-04T13:58:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dermatologia-leo-pharma-acquisisce-replay/ 2026-05-04T14:45:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-acquisisce-candid-therapeutics-scommessa-da-22-miliardi-di-dollari-sui-bispecifici-nelle-malattie-autoimmuni/ 2026-05-04T15:21:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diasorin-rafforza-la-leadership-nellimmunodiagnostica-con-la-nomina-di-gabriele-allegri-a-presidente/ 2026-05-04T17:02:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-q1-2026-in-crescita-sulla-spinta-dei-mercati-internazionali/ 2026-05-05T08:34:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-sanita-e-il-nuovo-campo-di-battaglia-dellia-ecco-come-le-big-tech-stanno-ridisegnando-linterfaccia-digitale-tra-pazienti-medici-e-dati-sulla-salute/ 2026-05-05T09:15:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-aifa-approva-rimborsabilita-di-darolutamide-piu-terapia-di-deprivazione-androgenica-nel-tumore-della-prostata/ 2026-05-05T09:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-vola-nel-primo-trimestre-e-alza-la-guidance-2026/ 2026-05-05T10:45:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-in-lombardia-impatto-da-467-milioni-di-euro-e-1-570-posti-di-lavoro-tra-diretti-e-indiretti/ 2026-05-05T13:54:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ceva-salute-animale-ian-tarpey-nuovo-executive-vp-innovation-e-rd-director/ 2026-05-05T14:25:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-il-monitoraggio-aifa-conferma-la-pressione-sugli-acquisti-diretti/ 2026-05-06T09:36:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-istituisce-un-gruppo-internazionale-sulla-fiducia-nei-vaccini/ 2026-05-06T09:45:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ispor-2026-mette-lheor-al-centro-di-accesso-valore-e-sostenibilita/ 2026-05-06T09:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-investe-sullia-per-integrare-ricerca-produzione-e-lancio/ 2026-05-06T09:57:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-breakthrough-ema-prova-un-canale-regolatorio-dedicato/ 2026-05-06T12:53:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-porta-a-cipro-il-confronto-sulla-competitivita-europea-nelle-life-sciences/ 2026-05-06T13:39:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-acquisisce-catalyst-pharmaceuticals-per-41-miliardi-di-dollari/ 2026-05-07T07:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-aifa-rimborsa-pirtobrutinib-per-la-leucemia-linfatica-cronica-recidivante-o-refrattaria/ 2026-05-07T08:39:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-italia-lancia-cardiocompass-lapp-immersiva-per-la-prevenzione-cardiovascolare/ 2026-05-07T09:48:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-aifa-e-aiom-rafforzano-la-collaborazione-sui-registri-di-monitoraggio/ 2026-05-07T10:31:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-punta-sui-sirna-accordo-da-1-miliardo-di-dollari-con-la-cinese-siranbio-per-candidato-malattie-cardiometaboliche/ 2026-05-07T12:47:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-rafforza-loftalmologia-acquisita-perfuse-per-245-miliardi-di-dollari/ 2026-05-07T13:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-animale-nasce-in-giappone-la-joint-venture-ceva-bussan-animal-health/ 2026-05-08T08:55:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-acquisisce-pathai-e-punta-sulla-digital-pathology-in-oncologia/ 2026-05-08T09:49:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-investe-45-miliardi-in-indiana-per-rafforzare-la-capacita-produttiva/ 2026-05-08T10:27:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-il-ministero-apre-le-porte-alle-associazioni/ 2026-05-08T12:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/un-lancio-senza-precedenti-gilead-alza-le-previsioni-del-primo-anno-di-lenacapivir-a-1-miliardo-di-dollari/ 2026-05-11T08:35:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-la-performance-passa-da-territorio-organizzazione-e-consiglio/ 2026-05-11T15:28:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-in-italia-a-sara-razzicchia-la-direzione-delle-risorse-umane/ 2026-05-11T10:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-innovative-medicine-italia-rimborsabilita-per-combo-amivantamab-lazertinib-nel-nsclc-avanzato/ 2026-05-11T16:12:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kedrion-con-bolognana-x3-maxi-investimento-nella-plasma-valley-italiana/ 2026-05-11T14:17:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cellular-intelligence-rilancia-la-terapia-cellulare-di-novo-nordisk-nel-parkinson/ 2026-05-12T08:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beone-da-aifa-via-libera-a-tislelizumab-per-tre-grandi-tumori-solidi/ 2026-05-12T09:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-essenziali-accordo-ue-contro-le-carenze-piu-produzione-in-europa-e-acquisti-comuni/ 2026-05-12T10:02:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/larte-entra-nella-sanita-in-italia-918-organizzazioni-prescrivono-cultura-come-terapia/ 2026-05-12T12:50:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-al-centro-del-piano-2026-2030-la-sfida-globale-di-daiichi-sankyo/ 2026-05-12T15:59:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-lilly-ecco-i-vincitori-della-prima-edizione-del-programma-30x30/ 2026-05-12T14:59:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-hengrui-alleanza-da-152-miliardi-su-oncologia-e-immunologia/ 2026-05-13T07:38:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/isomorphic-labs-raccoglie-21-miliardi-per-scalare-la-scoperta-di-farmaci-con-ia/ 2026-05-13T08:10:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pubblicita-dei-medicinali-aifa-fotografa-un-sistema-sempre-piu-digitale-ma-ancora-fragile-sulla-qualita-dei-materiali/ 2026-05-13T08:55:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infermieri-via-libera-alla-prescrizione-di-presidi-e-ausili-pubblicata-in-gu-la-riforma-delle-lauree/ 2026-05-13T09:07:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-di-tipo-1-solo-un-italiano-su-10-conosce-la-differenza-con-il-tipo-2/ 2026-05-13T11:55:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/molecular-tumor-board-nel-lazio-tavolo-con-clinici-operatori-e-associazioni-dei-pazienti/ 2026-05-13T12:59:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-vepdegestrant-primo-via-libera-a-una-terapia-protac/ 2026-05-13T14:36:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-voce-oltre-la-cura-pfizer-da-spazio-alla-qualita-di-vita-nel-tumore-al-seno-metastatico/ 2026-05-13T15:15:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parlamento-e-consiglio-ue-trovano-lintesa-sul-critical-medicines-act/ 2026-05-14T09:47:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ancora-nella-bufera-il-commissario-makary-si-dimette/ 2026-05-14T10:26:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-punta-su-m-a-per-rafforzare-la-pipeline/ 2026-05-14T14:23:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-i-progressi-della-salute-globale-sono-deboli-e-rischiano-di-arretrare/ 2026-05-14T15:24:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-chiude-un-q1-positivo-ma-restano-le-incognite-tra-ira-e-guerra-in-iran/ 2026-05-15T09:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-avanti-tutta-sul-farmaco-anti-tau-per-lalzheimer-nonostante-il-fallimento-dello-studio-di-fase-ii/ 2026-05-15T10:32:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-50-milioni-di-dollari-a-unicef-contro-le-malattie-croniche-infantili/ 2026-05-15T12:45:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-healthcare-nel-2026-digitale-on-top-negli-investimenti-pharma/ 2026-05-15T14:30:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-inclisiran-controllo-stabile-del-colesterolo-ldl-nel-tempo/ 2026-05-18T09:59:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-il-biopharma-usa-vuole-richard-pazdur-nuovo-commissario/ 2026-05-18T10:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-e-cellulari-nasce-cgtxchange-per-rilanciare-i-programmi-abbandonati/ 2026-05-18T12:31:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-marketing-il-futuro-e-il-presente-e-phygital/ 2026-05-18T13:42:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-farmaci-per-il-diabete-di-tipo-2-e-lobesita-da-aifa-guida-per-un-uso-consapevole/ 2026-05-18T14:34:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-verona-antonino-biroccio-gsk-eletto-vicepresidente-con-delega-alle-scienze-della-vita/ 2026-05-18T22:10:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-india-cresce-lambizione-globale-ma-resta-il-gap-con-la-cina/ 2026-05-19T09:00:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-in-europa-si-allungano-i-tempi-di-accesso-e-crescono-disuguaglianze-il-report-efpia/ 2026-05-19T09:32:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-parabilis-accordo-di-drug-discovery-da-23-miliardi-di-dollari/ 2026-05-19T12:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-artrite-psoriasica-bimekizumab-superiore-a-risankizumab-nello-studio-be-bold/ 2026-05-19T13:54:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmacie-solidali-rinnovato-il-protocollo-egualia-banco-farmaceutico-e-fofi/ 2026-05-19T14:35:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/frodi-e-abusi-gimbe-e-anac-accendono-i-riflettori-su-farmaci-e-device/ 2026-05-20T08:07:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-affida-i-public-affairs-a-giorgia-robaudo/ 2026-05-20T08:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xofluza-accordo-roche-mpp-generici-in-129-paesi-per-la-preparedness-pandemica/ 2026-05-20T08:23:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-hpv-correlati-aumenta-fiducia-nella-prevenzione-ma-lobiettivo-delleliminazione-e-ancora-lontano/ 2026-05-20T14:05:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-annuncia-la-nuova-presidente-e-il-nuovo-vicepresidente/ 2026-05-20T13:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-mirandola-istituzioni-imprese-e-stakeholder-a-confronto-sul-futuro-del-distretto-biomedicale-europeo/ 2026-05-20T14:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/infezioni-sessualmente-trasmissibili-in-aumento-lo-spallanzani-forma-gli-studenti/ 2026-05-21T15:29:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-aifa-approva-rimborsabilita-di-benralizumab-per-le-forme-recidivanti-o-refrattarie-di-egpa/ 2026-05-21T09:08:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bristol-myers-squibb-accordo-con-anthropic-per-integrare-il-modello-generativo-claude/ 2026-05-21T10:02:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-amplia-la-partnership-con-yuhan-accordo-da-140-milioni-di-dollari-per-la-fornitura-di-api/ 2026-05-21T10:32:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prima-della-cura-ci-sono-le-liste-dattesa-per-7-professionisti-su-10-sono-il-primo-ostacolo-allaccesso-e-cosi-e-boom-di-pazienti-che-si-rivolgono-al-privato-la-survey-di-quotidian/ 2026-05-21T12:17:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gho-capital-e-cbc-group-si-fondono-nasce-il-piu-grande-hub-globale-di-investimenti-healthcare/ 2026-05-21T13:03:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/integratori-alimentari-beauty-e-bisogni-funzionali-trainano-il-mercato-ma-leuropa-resta-frenata-dalla-normativa/ 2026-05-21T14:03:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-settima-acquisizione-del-2026-presa-engage-biologics-per-202-milioni-di-dollari/ 2026-05-22T08:31:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/qiagen-e-nvidia-partnership-per-lai-nella-drug-discovery/ 2026-05-22T08:59:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/europa-cresce-la-rete-scientifica-per-la-preparedness-il-know-how-della-fondazione-biotecnopolo-di-siena/ 2026-05-22T10:49:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-torna-la-crescita-nel-q1-lilly-domina-il-mercato/ 2026-05-22T12:52:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierre-fabre-da-chmp-parere-positivo-per-encorafenib-nella-terapia-di-prima-linea-del-mcrc-con-mutazione-braf/ 2026-05-22T13:33:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-opa-da-107-miliardi-di-euro-di-cvc-e-gbl-per-il-delisting/ 2026-05-22T14:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-con-loms-contro-la-leishmaniosi-viscerale/ 2026-05-25T09:22:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-ok-aifa-a-daratumumab-sottocutaneo-in-prima-linea-nel-mieloma-multiplo/ 2026-05-25T09:50:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-il-primo-farmaco-contro-lepatite-d-sara-commercializzato-da-gilead/ 2026-05-25T13:05:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-giuseppe-napolitano-la-guida-della-business-unit-rheumatology-di-abbvie-italia/ 2026-05-25T13:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/talassemia-da-ce-via-libera-al-farmaco-orfano-mitapivat-agios/ 2026-05-25T14:54:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-2026-ecco-i-trial-piu-attesi/ 2026-05-27T08:07:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/veterinari-indagine-boehringer-ingelheim-ruolo-chiave-ma-ancora-poco-riconosciuto/ 2026-05-26T16:27:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-ancora-sul-mercato-acquisite-altre-tre-biotech-per-38-miliardi-di-dollari/ 2026-05-27T08:07:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-laifa-aggiorna-la-lista-dei-medicinali-che-non-possono-mancare/ 2026-05-26T14:11:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-dispositivi-medici-asset-strategico-per-il-paese/ 2026-05-26T15:44:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-dati-positivi-per-filgotinib-nella-spondiloartrite-assiale-dallo-studio-di-fase-iii-olinguito/ 2026-05-27T12:41:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kedrion-dallema-designazione-di-farmaco-orfano-per-la-terapia-del-deficit-congenito-di-fattore-v/ 2026-05-27T09:06:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-in-italia-morena-caira-nuova-medical-affairs-director/ 2026-05-27T12:43:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-al-congresso-eas-2026-focus-su-acido-bempedoico-e-gestione-delle-dislipidemie/ 2026-05-27T10:48:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-introduce-un-pittogramma-ufficiale-per-le-note-informative-importanti-di-sicurezza/ 2026-05-27T11:57:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-investe-215-milioni-in-toscana-rosia-raddoppia-la-capacit-e-si-prepara-ai-vaccini-mrna/ 2026-05-27T12:15:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-zuckerberg-e-chan-lancia-modello-ai-open-source-per-le-proteine-e-la-progettazione-di-nuove-molecole/ 2026-05-27T14:56:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-ok-fda-a-datopotamab-deruxtecan-nel-tnbc/ 2026-05-28T10:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-morto-arturo-licenziati-presidente-e-ceo-del-gruppo/ 2026-05-28T12:53:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-in-italia-il-28-e-a-carico-dei-cittadini-fossc-garantire-sempre-diritto-alla-salute-e-terapie-innovative/ 2026-05-28T13:16:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-giapponese-limperativo-e-accelerare/ 2026-05-28T14:11:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aderenza-terapeutica-dalla-scarsa-comprensione-dei-benefici-agli-effetti-indesiderati-ecco-perche-un-paziente-su-3-non-segue-correttamente-le-cure-la-nuova-survey-di-quotidiano-sanita/ 2026-05-29T05:50:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nuovi-dati-su-seladelpar-nella-colangite-biliare-primitiva-presentati-a-easl-2026/ 2026-05-29T11:29:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gliomi-idh-mutati-nasce-in-piemonte-un-nuovo-modello-di-presa-in-carico/ 2026-05-29T12:50:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-a-palermo-medicina-di-precisione-appropriatezza-prescrittiva-e-governance-farmaceutica-al-centro-del-confronto-con-le-regioni/ 2026-05-29T13:41:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-ultra-rare-aifa-approva-rimborsabilita-akantior-per-la-cheratite-da-acanthamoeba/ 2026-05-29T14:24:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-innovent-biologics-accordo-da-105-miliardi-di-dollari-per-12-adc-oncologici/ 2026-05-29T14:48:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-aifa-via-libera-alla-rimborsabilita-di-4-nuovi-farmaci-5-estensioni-terapeutiche-e-2-equivalenti/ 2026-05-31T15:24:04+00:00 monthly 0.2